Categories
- Automotive
- Bearings
- Business Services
- Chemicals and Materials
- Coatings
- Company Profiles
- Consumer Goods
- Defense
- Electronics
- Energy
- Financial Services
- Food & Beverages
- Manufacturing & Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Public Sector
- Resins
- Technology
- Telecommunications and Wireless
- Vacuum Products
Popular Articles
Sorry. No data so far.
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design
US$ 2995The complex requirements of manufacturing biological drugs also apply to biosimilars, and these have been a significant barrier to the further expansion of the biosimilars market. A key challenge has been the knowledge gap under which biosimilars are developed, which arises from the fact that innovator product information remains proprietary and biosimilar manufacturers must adopt a reverse engineering process.
04-12 2017 Pages: 117Substance Abuse Deterrents and Treatments – An Assessment of the Technological, Competitive and R&D Landscape
US$ 2995GBI Research’s latest report, “”Substance Abuse Deterrents and Treatments – An Assessment of the Technological, Competitive and R&D Landscape””, discusses global trends in the substance abuse deterrents and addiction treatments market including the impact substance abuse is having on local economies, healthcare systems and society as a whole.
04-26 2016 Pages: 73Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies
US$ 2995GBI Research’s latest report, “”Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies””, provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare and associated sectors.
04-15 2016 Pages: 64The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
US$ 2995GBI Research’s latest report, “”The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects”” discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status.
02-01 2016 Pages: 67Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future
US$ 2995GBI Research’s latest report, “”Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future”” discusses fundamental concepts in biobanking and recent technology advancements in the field.
01-12 2016 Pages: 118Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity
US$ 2995“Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity”” discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances.
12-03 2015 Pages: 77Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook
US$ 2995Gene therapies have been in development in humans for 25 years, and a number of products have begun to enter the pharmaceutical market. However, due to various challenges and clinical trial setbacks, progress in developing this technology and achieving suitability for commercial usage has been slow.
10-12 2015 Pages: 43Opioids Overview to 2021 – An Assessment of Pain Management and Dependence
US$ 2995Analysis pertaining to the prescribed opioid users, treatment patterns, and market revenues confirms that the use of weak opioids has fallen dramatically in most markets, while the use of strong opioids has increased. The total market size in the countries covered in this report was $15.7 billion in 2014,
09-20 2015 Pages: 110Life Cycle Management Strategies – Optimizing revenues and defending generic competition
US$ 2995Life Cycle Management Strategies – Optimizing revenues and defending generic competition”” discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies,
08-16 2015 Pages: 100Contract Research Organization Market – Global Deals and Operational Strategies
US$ 2995“Contract Research Organization Market – Global Deals and Operational Strategies”” discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs.
07-06 2015 Pages: 77
